PPCB
NASDAQ
AU
Propanc Biopharma, Inc. - Common Stock
$0.12
▲ +$0.01
(+4.74%)
Vol 766K
1
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$7.2M
ROE
-1743.6%
Beta
3.33
52W
$1–$145
Price Chart
Similar Stocks
Fundamentals Trend
| Metric | 2024-12-31 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -1743.6% | -1743.6% | -1743.6% | -1743.6% | -1743.6% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | — | — | — | — | — | — |
| Current Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Ratios
ROA (TTM)
-2651.7%
EPS (TTM)
$-141.08
CF/Share
$-0.55
52W High
$145.46
52W Low
$0.58
$0.58
52-Week Range
$145.46
How does PPCB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PPCB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼
0%
below
peers
(2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PPCB profitability vs Biotechnology peers
ROE
-1743.6%
▼
2491%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-2651.7%
▼
5577%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
PPCB financial health vs Biotechnology peers
D/E ratio
—
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
0.0
▼
100%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
3.3
▲
244%
above
peers
(1.0)
vs Peers
vs Industry
More volatile
PPCB fundamentals radar
PPCB
Peer median
Industry
PPCB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PPCB vs peers: key metrics
Latest News
No related news yet